Authors: Gerhard F. Ecker; Peter Chiba

Source: Mini Reviews in Medicinal Chemistry, Volume 5, Number 2, February 2005 , pp. 125-125(1)

Publisher: Bentham Science Publishers

Abstract:

The problem of multidrug resistance has gained increasing importance in the fields of tumour therapy and treatment of bacterial and fungal infections. One of the major mechanisms responsible for development of multiple drug resistance is overexpression of drug efflux pumps. These membrane bound, ATP driven transport proteins efflux a wide variety of natural product toxins and chemotherapeutic drugs out of cells and give rise to decreased intracellular accumulation of these compounds. Thus, inhibition of efflux pumps is a versatile approach for overcoming multiple drug resistance, and several compounds are in clinical phase III studies. The main target is P-glycoprotein, which is responsible for MDR in tumour cells, and transport systems in S. aureus, P. aerugiosa and E. coli. Due to the fact, that 3D-structures of the proteins at atomic resolution were not available, drug development was performed solely on basis of ligand based design. However, electron microscopy studies as well as X-ray structures of three bacterial efflux pumps may open the door to target based drug design in the near future.

The hot topic issue will deal with the topic of drug efflux pumps from different perspectives. The article of Klopman and Zhu present new methodologies for estimating lipophilicity and their impact on prediction of membrane transport properties of drugs. Seelig and Gatlik-Landwojtowicz highlight the biophysical characterisation of inhibitors of efflux pumps and their membrane and protein interactions. An overview on the approaches used for lead identification and optimisation for inhibitors of P-glycoprotein is given by Pleban and Ecker. Peer et al. focus in their article on recent progress in identifying substrate binding domains of P-glycoprotein by means of photoaffinity labeling. Analogous multidrug transport systems in lactic acid bacteria are dealt by Mazurkiewicz et al. Last but not least Fischer et al. give an overview on the clinical relevance of efflux transporter. These articles will demonstrate, that, although much progress has been made in the development of EPIs, we are far away from understanding the basic principle of drug recognition and transport mechanism of this class of pumps. These issues will continue to be one of the major tasks in the field of modulation of drug resistance!

Document Type: Book review

DOI: http://dx.doi.org/10.2174/1389557053402710

Affiliations: 1: Department of Pharmaceutical Chemistry University of Vienna (GFE) and Department of Medical Chemistry Medical University of Vienna Vienna Austria.

Publication date: 2005-02-01

More about this publication?

• The aim of Mini-Reviews in Medicinal Chemistry is to publish short reviews on the important recent developments in medicinal chemistry and allied disciplines.
  
  The scope of Mini-Reviews in Medicinal Chemistry will cover all areas of medicinal chemistry including developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, drug targets, and natural product research and structure-activity relationship studies.
  
  Mini-Reviews in Medicinal Chemistry is an essential journal for every medicinal and pharmaceutical chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Related content

• In this: publication
• By this: publisher
• In this Subject: Chemistry (General) ,  Pharmacology
• By this author: Gerhard F. Ecker ;  Peter Chiba

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers